Literature DB >> 9581214

Electroconvulsive therapy for epilepsy and major depression.

W T Regenold1, D Weintraub, A Taller.   

Abstract

In this first report of electroconvulsive therapy (ECT) for the simultaneous treatment of seizures and depressive episodes, the authors discuss the use of ECT in the treatment of complex-partial seizures and major depression in a geriatric patients who refused antidepressant and antiepileptic medication. ECT has numerous anticonvulsant effects, including elevated seizure threshold and decreased seizure duration, which make it a useful adjunctive therapy in epilepsy that is refractory or not amenable to treatment with medication.

Entities:  

Mesh:

Year:  1998        PMID: 9581214

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  7 in total

1.  Maintaining electroconvulsive therapy for refractory epilepsy combined with psychotic symptoms.

Authors:  Farn-Jong Koong; Wen-Ching Chen
Journal:  BMJ Case Rep       Date:  2010-12-29

2.  Suicide in Neurologic Illness.

Authors:  David B. Arciniegas; C. Alan Anderson
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

3.  Bipolar Disorder in Neurologic Illness.

Authors:  Christopher D. Schneck
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

Review 4.  [Electric brain stimulation for epilepsy therapy].

Authors:  C Kellinghaus; T Loddenkemper; G Möddel; F Tergau; J Lüders; P Lüdemann; D R Nair; H O Lüders
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

5.  Pharmacotherapy of Mood Disorders in Epilepsy: The Role of Newer Psychotropic Drugs.

Authors:  Andres M Kanner; Antoaneta J Balabanov
Journal:  Curr Treat Options Neurol       Date:  2005-07       Impact factor: 3.972

6.  Mood Disorders in Neurologic Illness.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

Review 7.  Electroconvulsive therapy and its different indications.

Authors:  Thomas C Baghai; Hans-Jürgen Möller
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.